The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: LEVOFLOXACIN.     Injury: Respiratory muscle weakness     Quarter: 2016Q3

Total Records: 13     Number of Pages: 1

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
118303684 LEVOFLOXACIN. Respiratory muscle weakness JANSSEN 55.00 YR F 0 20160714 US
118335622 LEVOFLOXACIN. Respiratory muscle weakness TEVA 28.00 YR F 0 20160712 US
118335792 LEVOFLOXACIN. Respiratory muscle weakness TEVA 46.00 YR M 0 20160712 US
118699183 LEVOFLOXACIN. Respiratory muscle weakness AUROBINDO 55.00 YR F 0 20160718 US
118699353 LEVOFLOXACIN. Respiratory muscle weakness AUROBINDO 28.00 YR F 0 20160830 US
125477821 LEVOFLOXACIN. Respiratory muscle weakness MACLEODS 0.00 0 20160712 GB
125477831 LEVOFLOXACIN. Respiratory muscle weakness MACLEODS 0.00 0 20160712 GB
125477931 LEVOFLOXACIN. Respiratory muscle weakness MACLEODS 0.00 0 20160712 GB
125478851 LEVOFLOXACIN. Respiratory muscle weakness GLENMARK 0.00 0 20160712 US
125553681 LEVOFLOXACIN. Respiratory muscle weakness GLENMARK 28.00 YR F 0 20160714 US
125557461 LEVOFLOXACIN. Respiratory muscle weakness GLENMARK 55.00 YR F 0 20160714 US
126743711 LEVOFLOXACIN. Respiratory muscle weakness TEVA 28.00 YR F 0 20160822 US
126751061 LEVOFLOXACIN. Respiratory muscle weakness TEVA 46.00 YR M 0 20160823 US

Total Records: 13     Number of Pages: 1